Emergent BioSolutions faces questions from lawmakers in vaccine probe

Visits: 10

The biotech firm Emergent BioSolutions is facing a congressional inquiry Wednesday over alleged deficiencies in their manufacturing of COVID-19 vaccine ingredients. Read More Go To Source